Long-term efficacy and safety of ravulizumab in adults with AChR-Ab plus gMG: final results from the phase 3 CHAMPION MG open-label extension

被引：0
|
作者：
Vu, T. [1 ]
Mantegazza, R. [2 ]
Annane, D. [3 ]
Katsuno, M. [4 ]
Meisel, A. [5 ]
Nicolle, M. [6 ]
Bril, V. [7 ]
Aguzzi, R. [8 ]
Frick, G. [8 ]
Howard, J., Jr. [9 ]
机构：
[1] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Hop Raymond Poincare, Garches, France
[4] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[5] Charite Univ Med Berlin, Berlin, Germany
[6] London Hlth Sci Ctr, London, ON, Canada
[7] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[8] Alexion, AstraZeneca Rare Dis, Boston, MA USA
[9] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
NEUROMUSCULAR DISORDERS | 2024年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
506VP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Meisel, Andreas
    Annane, Djillali
    Vu, Tuan
    Mantegazza, Renato
    Katsuno, Masahisa
    Aguzzi, Rasha
    Frick, Glen
    Gault, Laura F.
    Howard Jr, James
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3862 - 3875
  • [2] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Andreas Meisel
    Djillali Annane
    Tuan Vu
    Renato Mantegazza
    Masahisa Katsuno
    Rasha Aguzzi
    Glen Frick
    Laura Gault
    James F. Howard
    Journal of Neurology, 2023, 270 : 3862 - 3875
  • [3] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [4] LONG-TERM EFFICACY AND SAFETY OF RAVULIZUMAB, A LONG-ACTING TERMINAL COMPLEMENT INHIBITOR, IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: RESULTS FROM THE PHASE 3 CHAMPION MG OPEN-LABEL EXTENSION
    Vu, Tuan
    Meisel, Andreas
    Mantegazza, Renato
    Annane, Djillali
    Katsuno, Masahisa
    Aguzzi, Rasha
    Rampal, Nishi
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 65 : S2 - S3
  • [5] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [6] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [7] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [8] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [10] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
12345